|   | 
        Supplementation (n=7) | 
        Placebo (n=6) | 
        Comparisonaa) | 
       
      
        | Variables:    mean (SD) | 
        4 week | 
        8 week | 
        12 week | 
        16 week | 
        4 week | 
        8 week | 
        12 week | 
        16 week | 
        F | 
        P | 
       
      
        | ADI-R repetitive    behavior domains | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
       
      
        Encopassin b) 
                 
          preoccupatuion  | 
        3.1 (1.5) | 
        3.4 (0.8) | 
        3.0 (1.5) | 
        2.6 (1.5) | 
        2.8 (1.6) | 
        2.0 (1.8) | 
        2.3 (1.6) | 
        2.0 (1.8) | 
        1.46 | 
        0.25 | 
       
      
        Compulsive 
                 
          adherencebc) | 
        1.4 (1.5) | 
        0.7 (0.8) | 
        2.9 (1.6) | 
        0.0 (0.0) | 
        0.5 (1.2) | 
        0.3 (0.8) | 
        1.8 (1.8) | 
        0.0 (0.0) | 
        0.59 | 
        0.62 | 
       
      
        Stereotyped and     repetitive 
                 
          motor mannerismsd) | 
        0.0 (0.0) | 
        0.0 (0.0) | 
        0.0 (0.0) | 
        0.0 (0.0) | 
        0.8 (1.6) | 
        0.3 (0.8) | 
        0.2 (0.4) | 
        0.0 (0.0) | 
        3.18 | 
        0.04* | 
       
      
        Preoccupation    with   
                 
          parts  of objectse) | 
        2.3 (1.5) | 
        2.3 (1.1) | 
        2.1 (1.3) | 
        1.7 (1.4) | 
        2.0 (1.3) | 
        1.8 (1.2) | 
        2.1 (1.3) | 
        1.5 (1.2) | 
        1.15 | 
        0.35 | 
       
      
        | ABC | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
          | 
       
      
        | Irritability | 
        13.0 (11.6) | 
        10.6 (10.4) | 
        14.4 (14.3) | 
        8.9 (9.9) | 
        8.2 (7.7) | 
        8.3 (6.3) | 
        8.0 (7.1 | 
        9.2 (8.8) | 
        1.78 | 
        0.17 | 
       
      
        | Social    withdrawal | 
        22.1 (4.6) | 
        13.3 (3.8) | 
        14.4 (8.8) | 
        10.9 (5.1) | 
        18.0 (2.8) | 
        18.2 (7.1) | 
        15.0 (5.1) | 
        17.7 (4.3) | 
        3.08 | 
        0.04* | 
       
      
        | Stereotypy | 
        5.1 (4.5) | 
        2.4 (2.9) | 
        4.4 (7.5) | 
        3.4 ( 4.9) | 
        3.8 (4.5) | 
        2.7 (3.8) | 
        4.0 (4.3) | 
        5.2 (5.7) | 
        0.66 | 
        0.58 | 
       
      
        | Hyperactivity | 
        15.0 (9.6) | 
        9.0 (8.4) | 
        14.6 (12.6) | 
        12.0 (10.7) | 
        14.2 (14.1) | 
        12.0 (9.4) | 
        15.7 (7.6) | 
        15.3 (8.1) | 
        0.65 | 
        0.59 | 
       
      
        | Inappropriate    speech | 
        3.7 (3.6) | 
        3.0 (3.1) | 
        4.4 (4.9) | 
        3.7 (3.9) | 
        3.8 (2.1) | 
        3.8 (2.1) | 
        4.0 (2.8) | 
        5.3 (4.1) | 
        0.79 | 
        0.51 | 
       
      | 
  
  
    Treatment group received supplementation with arachidonic acid (ARA) and docosahexaenoic acid (DHA) for 16 weeks. 
      ADI-R, Autism Diagnostic Interview- Revised; ABC, Aberrant Behavior Checklist. 
      1) Repeated measures analysis of variance (ANOVA) was used when baseline scores as a covariate with treatment as the between-subject-factor and test session repeated 
      factor, * P<0.05. 
      2) ADI-R algorithm item C 1: Encompassing preoccupation or circumscribed pattern of interest. 
      3) ADI-R algorithm item C 2: Apparently compulsive adherence to nonfunctional routines or rituals. 
      4) ADI-R algorithm item C 3: Stereotyped and repetitive motor mannerisms. 
    5) ADI-R algorithm item C 4: Preoccupation with parts of objects or nonfunctional elements of materials. | 
  
  
    | Table 2: Mean scores on the Aberrant Behavior Checklist (ABC) and the Social Responsiveness Scale (SRS) for a 16-week randomized double-blind placebo-controlled trial. |